Defender Capital, Llc. Oncocyte Corp Transaction History

Defender Capital, Llc.

$255 Million
Q4 2024

A detailed history of Defender Capital, Llc. transactions in Oncocyte Corp stock. As of the latest transaction made, Defender Capital, Llc. holds 47,078 shares of OCX stock, worth $92,272. This represents 0.05% of its overall portfolio holdings.

Number of Shares

47,078

Previous 59,353 20.68%

Holding current value

$92,272

Previous $169,000 31.36%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$2.11 - $3.15 $25,900 - $38,666	-12,275 Reduced 20.68%	47,078 $116,000
Q3 2024 Oct 21, 2024	BUY	$2.85 - $3.36 $11,779 - $13,886	4,133 Added 7.48%	59,353 $169,000
Q2 2024 Jul 29, 2024	SELL	$2.44 - $3.07 $1,622 - $2,041	-665 Reduced 1.19%	55,220 $162,000
Q1 2024 May 06, 2024	SELL	$2.84 - $3.6 $44,772 - $56,754	-15,765 Reduced 22.0%	55,885 $163,000
Q4 2023 Jan 23, 2024	SELL	$2.08 - $4.26 $89,169 - $182,626	-42,870 Reduced 37.43%	71,650 $179,000
Q3 2023 Oct 23, 2023	SELL	$0.2 - $4.28 $442,682 - $9.47 Million	-2,213,410 Reduced 95.08%	114,520 $357,000
Q2 2023 Jul 18, 2023	SELL	$0.2 - $0.35 $7,100 - $12,425	-35,500 Reduced 1.5%	2,327,930 $535,000
Q1 2023 Apr 27, 2023	BUY	$0.2 - $0.49 $18,100 - $44,345	90,500 Added 3.98%	2,363,430 $827,000
Q4 2022 May 16, 2023	SELL	$0.25 - $15.6 $22,625 - $1.41 Million	-90,500 Reduced 3.83%	2,272,930 $727,000
Q4 2022 Jan 12, 2023	SELL	$0.25 - $15.6 $69,762 - $4.35 Million	-279,050 Reduced 10.93%	2,272,930 $729,000
Q3 2022 Oct 18, 2022	SELL	$0.76 - $15.98 $28,424 - $597,652	-37,400 Reduced 1.44%	2,551,980 $1.88 Million
Q2 2022 Jul 26, 2022	BUY	$0.86 - $1.53 $23,435 - $41,692	27,250 Added 1.06%	2,589,380 $2.33 Million
Q1 2022 Apr 22, 2022	BUY	$1.15 - $2.25 $397,129 - $776,992	345,330 Added 15.58%	2,562,130 $4 Million
Q4 2021 Feb 01, 2022	BUY	$2.04 - $3.59 $522,199 - $918,968	255,980 Added 13.05%	2,216,800 $4.81 Million
Q3 2021 Nov 01, 2021	BUY	$3.53 - $5.89 $2.17 Million - $3.61 Million	613,620 Added 45.55%	1,960,820 $6.94 Million
Q2 2021 Jul 29, 2021	BUY	$3.77 - $6.0 $2.8 Million - $4.46 Million	742,750 Added 122.88%	1,347,200 $7.73 Million
Q1 2021 Apr 20, 2021	BUY	$2.39 - $6.5 $1.44 Million - $3.93 Million	604,450 New	604,450 $3.12 Million

Others Institutions Holding OCX

# of Institutions

Shares Held

399K

Call Options Held

Put Options Held

View Full List

About Oncocyte Corp

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $232M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

More about OCX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Defender Capital, Llc. with notifications on news.

Account

Defender Capital, Llc. Oncocyte Corp Transaction History